Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carmil Drops
- Development stage
- Unknown
- Lead developer
- Libra Drugs
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Carmil Drops is an Ayurvedic herbal formulation developed and manufactured by Libra Drugs. It is formulated as oral drops containing a synergistic blend of traditional herbal ingredients, including Drakshasava, Embelia ribes, Hingashtak, and Zingiber officinale (ginger). Carmil Drops is primarily indicated for pediatric use to support digestive health, relieve infantile colic, flatulence, and indigestion, and to act as a carminative and appetite stimulant.
- Brand names
- Carmil Drops
- Other names
- Carmil
Beyond the preview
Go deeper on Carmil Drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Carmil Drops.